OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies
Lavinia Ghiani, Susanna Chiocca
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3483-3483
Open Access | Times Cited: 22

Showing 22 citing articles:

CellEnBoost: A Boosting-Based Ligand-Receptor Interaction Identification Model for Cell-to-Cell Communication Inference
Lihong Peng, Ruya Yuan, Chendi Han, et al.
IEEE Transactions on NanoBioscience (2023) Vol. 22, Iss. 4, pp. 705-715
Closed Access | Times Cited: 28

Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis
Arash Letafati, Zahra Taghiabadi, Negar Zafarian, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3

Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment
Christine McInnis, Shilpa Bhatia, Brinda Vijaykumar, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 3, pp. e006721-e006721
Open Access | Times Cited: 5

Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma
Qimin Zhou, Ouyang Yuan, Hongtu Cui, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 9

A prognostic model built on amino acid metabolism patterns in HPV-associated head and neck squamous cell carcinoma
Fengyang Jing, Lijing Zhu, Jiaying Bai, et al.
Archives of Oral Biology (2024) Vol. 163, pp. 105975-105975
Closed Access | Times Cited: 1

Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers
Anastasia Demidova, Laëtitia Douguet, Ingrid Fert, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 674-687
Open Access | Times Cited: 1

Head and neck squamous cell carcinoma: Exploring frontiers of combinatorial approaches with tyrosine kinase inhibitors and immune checkpoint therapy
João Figueira Scarini, Luccas Lavareze, Reydson Alcides de Lima‐Souza, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103863-103863
Closed Access | Times Cited: 6

MYO1B as a prognostic biomarker and a therapeutic target in Arecoline‐associated oral carcinoma
Zhen Sun, Xiaopeng Guo, Huarong Chen, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 7, pp. 920-939
Closed Access | Times Cited: 3

The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
Julia Fleischmann, Laura S. Hildebrand, Lukas Kuhlmann, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1653-1653
Open Access | Times Cited: 3

Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis
Saniya Arfin, Dhruv Kumar, Andrea Lomagno, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4420-4420
Open Access | Times Cited: 3

Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy
Adib Miraki Feriz, Fatemeh Bahraini, Arezou Khosrojerdi, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295863-e0295863
Open Access | Times Cited: 3

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
Cheng Lin, Yuebing Chen, Jianji Pan, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Epidemiology, pathology, and genomic topography of head and neck cancers
Ritu Pandey, Ashok Kumar, Tulasi Sindhuja, et al.
Elsevier eBooks (2024), pp. 1-21
Closed Access

Epigenetic Changes Induced by Infectious Agents in Cancer
Fabiola E. Tristán‐Flores, Carmen de la Rocha, Raquel Pliego-Arreaga, et al.
(2024), pp. 411-457
Closed Access

Radiomic features of dynamic contrast-enhanced MRI can predict Ki-67 status in head and neck squamous cell carcinoma
Lu Yang, Longwu Yu, Guangzi Shi, et al.
Magnetic Resonance Imaging (2024) Vol. 116, pp. 110276-110276
Closed Access

THE ONCOGENIC ROLE OF THE NSD HISTONE METHYLTRANSFERASES IN HEAD AND NECK AND CERVICAL CANCERS
Lavinia Ghiani, Susanna Chiocca
Tumour Virus Research (2024), pp. 200301-200301
Open Access

Potential use of lapatinib in the treatment of head and neck squamous cell carcinoma (Review)
Christina Healthyni, Toto Subroto, Sandra Megantara, et al.
World Academy of Sciences Journal (2022) Vol. 4, Iss. 5
Open Access | Times Cited: 2

Molecular and clinical aspects of HNSCC in the Republic of Moldova
Valentina Stratan, Ţuţuianu Valeri, Victor Sîtnic, et al.
Revista română de medicină de laborator (2023) Vol. 31, Iss. 4, pp. 285-290
Open Access

Page 1

Scroll to top